Evidence map›Paper›PMID 25886458›Full record

ReviewJournal of translational medicine2015

Aquaporins as diagnostic and therapeutic targets in cancer: how far we are?

Jian Wang, Li Feng, Zhitu Zhu, Minghuan Zheng, Diane Wang, Zhihong Chen, Hongzhi Sun

Open access · goldAbstract readReview
In one paragraph

Review in Journal of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Aquaporins: Potential Targets in Inflammatory Diseases.The Eurasian journal of medicine · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Aquaporin-mediated dysregulation of cell migration in disease states.Cellular and molecular life sciences : CMLS · 2023
    Review
  18. Review
  19. Aquaporins in Tumor.Advances in experimental medicine and biology · 2023
    Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jian WangDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. 251328610@qq.com.
Li FengMinghang Hospital, Fudan University, Shanghai, China. fengweihong66666@sina.cn.
Zhitu ZhuThe First Hospital of Liaoning Medical University, Jingzhou, China. zhuzhitu@163.com.
Minghuan ZhengDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. minghuan_zheng@qq.com.
Diane WangDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. wang_rei@hotmail.com.
Zhihong ChenDepartment of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, China. chen.zhihong@zs-hospital.sh.cn.
Hongzhi SunThe First Hospital of Liaoning Medical University, Jingzhou, China. cmushz@163.com.
Jinzhou Medical University · CNObstetrics and Gynecology Hospital of Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aquaporins (AQPs) are a family of water channel proteins distributed in various human tissues, responsible for the transport of small solutes such as glycerol, even gas and ions. The expression of AQPs has been found in more than 20 human cancer types and is significantly correlated with the severity of histological tumors and prognosis of patients with cancer. More recent evidence showed that AQPs could also play a role in tumor-associated edema, tumor cell proliferation and migration, and tumor angiogenesis in solid and hematological tumors. Inhibitors of AQPs in tumor cells and microvessels have been suggested as new therapeutic strategies. The present review overviews AQPs structures, expression variation among normal tissues and tumors, AQPs functions and roles in the development of cancer with special focuses on lung, colorectal, liver, brain and breast cancers, and potential AQPs-target inhibitors. We call the special attention to consider AQPs important as diagnostic and therapeutic biomarkers. It may be a novel anticancer therapy by the AQPs inhibition.

Indexed as

Molecular Targeted TherapyAnimalsAquaporinsHumansModels, BiologicalNeoplasmsAquaporins

Identifiers

PMID25886458
PMCPMC4382841
OpenAlexW2142311430

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.